According to recently released poll results, nearly 3 in 5 Canadians agree that companies should be able to administer drug tests to any employee now that cannabis is legal.

The results of the online survey, carried out by Research Co. in October 2023 using a representative national sample, show that 58% of Canadians believe these drug tests should “definitely” or “probably” be allowed, which corresponds to a two-point decrease compared to the results of a previous poll conducted in October 2022.

Nearly 7 in 10 Canadians are in favour of the federal government granting pardons, thereby destroying or removing any judicial record of a conviction, to individuals convicted of possession of cannabis for personal use with no intent to traffic, which corresponds to a 5 point increase compared to previous survey results.

In addition, the survey showed that support in favour of pardons for individuals convicted of possession of cannabis for personal use with no intent to traffic was highest in Ontario (72%), followed by Saskatchewan and Manitoba (71%), Alberta (70%), Quebec (68%), Atlantic Canada (65%) and British Columbia (65%). Overall, 64% of Canadians agree with cannabis legalization, while 31% disagree with it.

“Support for the legalization of marijuana is highest among Canadians aged 55 and over (66%),” said Mario Canseco, President of Research Co., in a press release. “The proportions are lower among those aged 35-to-54 (56%) and those aged 18-to-34 (48%).”

However, only 1 in 8 Canadians expressed support for legalizing other illicit substances, such as ecstasy (12%), powder cocaine (also 12%), heroin (10%), crack cocaine (also 10%), methamphetamine or “crystal meth” (9%) and fentanyl (also 9%).

The results also demonstrated that more than half of respondents (53%) claim to have never consumed cannabis in Canada, while 33% said they tried cannabis before legalization, and 13% only used it after it became legal in October 2018. Moreover, nearly half of respondents (48%) declared that all of their cannabis was acquired at a licensed retailer, while 17% said “none” of the cannabis they purchased was from a licensed retailer.